House Bill 323 – Meningococcal and Shingles Vaccines

Posted in Latest News on March 30, 2018.

House Bill 323 became law on July 1, 2014 as Chapter 2014-113, Laws of Florida. This law amended section 465.189, F.S., authorizing pharmacists to administer meningococcal and shingles vaccines under certain circumstances.

On April 12, 2018, amended rule 64B16-27.630, FAC, will become effective adding the Zoster Vaccine Recombinant, Adjuvanted to the immunizations or vaccines which may be administered by a Florida licensed pharmacist. Zoster Vaccine Recombinant, Adjuvanted is the proper name of the Shingrix® vaccine developed by GlaxoSmithKline.1 Shingrix® has been recommended by the CDC, and has been added to the Adult Immunization Schedule, effective February 2018. 2

1https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/shingrix/pi/home.html

2https://www.cdc.gov/vaccines/schedules/hcp/adult.html

 



More Latest News

Important notice regarding Rhopressa
February 12, 2019

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa. Continue reading


Florida Jurisprudence CE Requirement
February 11, 2019

The Board of Optometry voted to waive the 2-hour Florida Jurisprudence requirement for all out-of-state licensees for the current biennium only. Click Here for more information. Continue reading